Table 1. Demographic and clinical characteristic of subjects.
| First-episode drug naive group (n = 36) |
Medicated group (n = 71) |
Control group (n = 59) |
|
|---|---|---|---|
| Age | 30.72 (8.591) | 30.86 (7.904) | 31.32 (9.228) |
| Male (Female) | 16 (20) | 25 (46) | 27(32) |
| Years of education | 13.22 (3.217) | 14.04(2.515) | 13.88 (3.057) |
| QOL | 66.00 (11.720) *** | 64.28 (10.751) *** | 86.72 (9.735) |
| SASS | 26.24 (5.255) *** | 27.25 (6.443) *** | 34.79 (5.199) |
| CWRT | 92.34 (8.247) | 93.74 (7.586) | 95.45 (4.306) |
| HAMD | 21.90 (4.647) ## | 16.11 (8.256) | — |
| HAMA | 19.41 (5.295) ## | 15.08 (7.646) | — |
| MADRS | 29.34 (8.217) # | 21.35 (11.341) | — |
Data are shown as mean (S.D).
* compared between the First episode/ Medicine treatment with Controls:
*** p < 0.001.
# compared between the First episode with Medicine treatment:
#p < 0.05,
##p < 0.01.
CWRT: Chinese Word Reading Test; SASS: Social Adaptation Self-evaluation Scale; QOL: Quality of Life; HAMD: The Hamilton depression rating scale; HAMA: The Hamilton anxiety scale; MADRS: Montgomery–Åsberg depression rating scale.